Literature DB >> 3366037

Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II).

H T Lynch1, P Watson, M Kriegler, J F Lynch, S J Lanspa, J Marcus, T Smyrk, R J Fitzgibbons, G Cristofaro.   

Abstract

Increasing recognition of the statistical burden posed by HNPCC (5 to 6 percent of all colorectal cancer) mandates that physicians have a better understanding of the genetics, natural history, and distinction between the hereditary site-specific variant (Lynch syndrome I) and the Cancer Family Syndrome (Lynch syndrome II). The authors report detailed cancer (all sites) family histories on two prototype families with Lynch syndrome I (Family R) and Lynch syndrome II (Family N), which have been under investigation for more than two decades. Emphasis is placed on shared clinicogenetic features; namely, early age of onset of colonic cancer (approximately age 44), multiple primary colonic cancer (24 percent of cases showed metachronous colonic cancer), predominance of proximal colonic cancer location (approximately 65 percent in the proximal colon), and vertical transmission consonant with an autosomal dominantly inherited factor. An increased predilection for extracolonic cancer, particularly endometrial carcinoma, occurs in Lynch syndrome II and is the primary basis for distinction from Lynch syndrome I. Surveillance and management programs must be wholly responsive to these natural history features.

Entities:  

Mesh:

Year:  1988        PMID: 3366037     DOI: 10.1007/bf02564888

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  19 in total

1.  Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta.

Authors:  P J Westlake; H E Bryant; S A Huchcroft; L R Sutherland
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

Review 2.  The evolution of colorectal cancer genetics-Part 1: from discovery to practice.

Authors:  Andrew T Schlussel; Ronald A Gagliano; Susan Seto-Donlon; Faye Eggerding; Timothy Donlon; Jeffrey Berenberg; Henry T Lynch
Journal:  J Gastrointest Oncol       Date:  2014-10

3.  Expression of the hMLH1 and hMSH2 proteins in normal tissues: relationship to cancer predisposition in hereditary non-polyposis colon cancer.

Authors:  Pavlína Plevová; Eva Sedláková; Jana Zapletalová; Anna Krepelová; Petra Skýpalová; Zdenek Kolár
Journal:  Virchows Arch       Date:  2004-12-10       Impact factor: 4.064

4.  Is surveillance of the small bowel indicated for Lynch syndrome families?

Authors:  G L ten Kate; J H Kleibeuker; F M Nagengast; M Craanen; A Cats; F H Menko; H F A Vasen
Journal:  Gut       Date:  2007-04-04       Impact factor: 23.059

5.  Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.

Authors:  Aung Ko Win; Joanne P Young; Noralane M Lindor; Katherine M Tucker; Dennis J Ahnen; Graeme P Young; Daniel D Buchanan; Mark Clendenning; Graham G Giles; Ingrid Winship; Finlay A Macrae; Jack Goldblatt; Melissa C Southey; Julie Arnold; Stephen N Thibodeau; Shanaka R Gunawardena; Bharati Bapat; John A Baron; Graham Casey; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; Robert W Haile; John L Hopper; Mark A Jenkins
Journal:  J Clin Oncol       Date:  2012-02-13       Impact factor: 44.544

6.  Cancer risks for MLH1 and MSH2 mutation carriers.

Authors:  James G Dowty; Aung K Win; Daniel D Buchanan; Noralane M Lindor; Finlay A Macrae; Mark Clendenning; Yoland C Antill; Stephen N Thibodeau; Graham Casey; Steve Gallinger; Loic Le Marchand; Polly A Newcomb; Robert W Haile; Graeme P Young; Paul A James; Graham G Giles; Shanaka R Gunawardena; Barbara A Leggett; Michael Gattas; Alex Boussioutas; Dennis J Ahnen; John A Baron; Susan Parry; Jack Goldblatt; Joanne P Young; John L Hopper; Mark A Jenkins
Journal:  Hum Mutat       Date:  2013-03       Impact factor: 4.878

7.  Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer.

Authors:  P Gaglia; W S Atkin; S Whitelaw; I C Talbot; C B Williams; J M Northover; S V Hodgson
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

Review 8.  Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer.

Authors:  R W Burt; D T Bishop; H T Lynch; P Rozen; S J Winawer
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

9.  Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage.

Authors:  M Nyström-Lahti; R Parsons; P Sistonen; L Pylkkänen; L A Aaltonen; F S Leach; S R Hamilton; P Watson; E Bronson; R Fusaro
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

10.  Genetic transmission of colorectal cancer: exploratory data analysis from a population based registry.

Authors:  M Ponz de Leon; C Scapoli; G Zanghieri; R Sassatelli; C Sacchetti; I Barrai
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.